140 related articles for article (PubMed ID: 12205256)
21. Thyroxine administration to infants of less than 30 weeks gestational age decreases plasma tri-iodothyronine concentrations.
van Wassenaer AG; Kok JH; Dekker FW; Endert E; de Vijlder JJ
Eur J Endocrinol; 1998 Nov; 139(5):508-15. PubMed ID: 9849815
[TBL] [Abstract][Full Text] [Related]
22. Relationship between free T4 levels and postnatal steroid therapy in preterm infants.
Arai H; Goto R; Matsuda T; Takahashi T
Pediatr Int; 2009 Dec; 51(6):800-3. PubMed ID: 19419509
[TBL] [Abstract][Full Text] [Related]
23. Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial.
Uchiyama A; Kushima R; Watanabe T; Kusuda S
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):177-82. PubMed ID: 25153575
[TBL] [Abstract][Full Text] [Related]
24. Hypothyroxinemia Detected at 4 Weeks of Life in Preterm Infants Born at Less than 30 Weeks of Gestation.
Kaluarachchi DC; Colaizy TT; Lasarev MR; Allen DB; Klein JM
Am J Perinatol; 2021 Oct; 38(12):1271-1276. PubMed ID: 32498093
[TBL] [Abstract][Full Text] [Related]
25. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.
Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Bucher HU; Fauchère JC;
JAMA; 2016 May; 315(19):2079-85. PubMed ID: 27187300
[TBL] [Abstract][Full Text] [Related]
26. Effect of thyroxine on brain microstructure in extremely premature babies: magnetic resonance imaging findings in the TIPIT study.
Ng SM; Turner MA; Gamble C; Didi M; Victor S; Atkinson J; Sluming V; Parkes LM; Tietze A; Abernethy LJ; Weindling AM
Pediatr Radiol; 2014 Aug; 44(8):987-96. PubMed ID: 24671720
[TBL] [Abstract][Full Text] [Related]
27. Somatosensory evoked potentials in very preterm infants in relation to L-thyroxine supplementation.
Smit BJ; Kok JH; de Vries LS; van Wassenaer AG; Dekker FW; Ongerboer de Visser BW
Pediatrics; 1998 May; 101(5):865-9. PubMed ID: 9565416
[TBL] [Abstract][Full Text] [Related]
28. Correlation Between Thyroid Hormone Concentrations and Ultrasound Thyroid Volume in Preterm Infants Born Before 33 Weeks of Gestation.
Mikołajczak A; Kufel K; Bokiniec R
Front Endocrinol (Lausanne); 2022; 13():860716. PubMed ID: 35620396
[TBL] [Abstract][Full Text] [Related]
29. Reference range of thyroid hormones in very low birth weight infants at the time of discharge.
Chan DK; Tagamolila V; Ardhanari J; Lim XY; Wong J; Yeo CP
Thyroid; 2014 Jan; 24(1):73-7. PubMed ID: 23879206
[TBL] [Abstract][Full Text] [Related]
30. Motor nerve conduction velocity in very preterm infants in relation to L-thyroxine supplementation.
Smit BJ; Kok JH; de Vries LS; van Wassenaer AG; Dekker FW; Ongerboer de Visser BW
J Pediatr; 1998 Jan; 132(1):64-9. PubMed ID: 9470002
[TBL] [Abstract][Full Text] [Related]
31. Preterm and term-equivalent age general movements and 1-year neurodevelopmental outcomes for infants born before 30 weeks' gestation.
Olsen JE; Allinson LG; Doyle LW; Brown NC; Lee KJ; Eeles AL; Cheong JLY; Spittle AJ
Dev Med Child Neurol; 2018 Jan; 60(1):47-53. PubMed ID: 28940492
[TBL] [Abstract][Full Text] [Related]
32. Thyroxine for transient hypothyroxinemia and cerebral palsy in extremely preterm infants.
Suzumura H; Nitta A; Tsuboi Y; Watabe Y; Kuribayashi R; Arisaka O
Pediatr Int; 2011 Aug; 53(4):463-7. PubMed ID: 21054676
[TBL] [Abstract][Full Text] [Related]
33. Establishment of hormone reference intervals for infants born < 30 weeks' gestation.
Greaves RF; Zacharin MR; Donath SM; Inder TE; Doyle LW; Hunt RW
Clin Biochem; 2014 Oct; 47(15):101-8. PubMed ID: 24927648
[TBL] [Abstract][Full Text] [Related]
34. Postnatal thyroxine supplementation in infants less than 32 weeks' gestation: effects on pulmonary morbidity.
Smith LM; Leake RD; Berman N; Villanueva S; Brasel JA
J Perinatol; 2000; 20(7):427-31. PubMed ID: 11076326
[TBL] [Abstract][Full Text] [Related]
35. Establishing a reference range for triiodothyronine levels in preterm infants.
Oh KW; Koo MS; Park HW; Chung ML; Kim MH; Lim G
Early Hum Dev; 2014 Oct; 90(10):621-4. PubMed ID: 25150803
[TBL] [Abstract][Full Text] [Related]
36. Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia.
Chowdhry P; Scanlon JW; Auerbach R; Abbassi V
Pediatrics; 1984 Mar; 73(3):301-5. PubMed ID: 6366725
[TBL] [Abstract][Full Text] [Related]
37. Hypothyroxinemia of prematurity and infant neurodevelopment: a pilot study.
Ishaik G; Asztalos E; Perlman K; Newton S; Frisk V; Rovet J
J Dev Behav Pediatr; 2000 Jun; 21(3):172-9. PubMed ID: 10883877
[TBL] [Abstract][Full Text] [Related]
38. The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease.
Matsuura N; Harada S; Ohyama Y; Shibayama K; Fukushi M; Ishikawa N; Yuri K; Nakanishi M; Yokota Y; Kazahari K; Oguchi H
Pediatr Res; 1997 Aug; 42(2):214-8. PubMed ID: 9262225
[TBL] [Abstract][Full Text] [Related]
39. Does parenchymal brain injury affect biobehavioral pain responses in very low birth weight infants at 32 weeks' postconceptional age?
Oberlander TF; Grunau RE; Fitzgerald C; Whitfield MF
Pediatrics; 2002 Sep; 110(3):570-6. PubMed ID: 12205262
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the effect of thyroxine supplementation on behavioural outcome in very preterm infants.
Briët JM; van Wassenaer AG; van Baar A; Dekker FW; Kok JH
Dev Med Child Neurol; 1999 Feb; 41(2):87-93. PubMed ID: 10075094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
